查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1236108

2022-2029 年尿路感染药物全球市场规模调查和预测，按药物、适应症、地区分析

Global Urinary Tract Infection Therapeutics Market Size study & Forecast, by Drug, by Indication, and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

2021 年全球尿路感染药物市场价值约 86.6 亿美元，稳步增长，2022-2029 年预测期内增长率超过 3% 据预测

尿路感染是最常见的细菌感染之一，女性发病率高于男性。 侵入泌尿道。 由于肾结石和糖尿病的患病率增加以及联合药物的推出等因素，尿路感染药物市场正在扩大。

根据世界卫生组织 2019 年的数据，糖尿病在全球造成约 150 万人死亡，目前全球估计有 5.37 亿人受到糖尿病的影响。 到 2045 年，预计全球将有 7.83 亿糖尿病患者。 另一方面，日益严重的人口老龄化和市场参与者增加的研发活动正在为市场创造有利可图的机会。 然而，其在新兴国家的低意识将阻碍 2022-2029 年预测期内的市场增长。

尿路感染药物全球市场研究考虑的主要区域是亚太地区、北美、欧洲、拉丁美洲和世界其他地区。 由于肾结石和糖尿病的患病率增加，北美在销售方面占据市场主导地位。 由于尿路结石意识的提高、个人护理支出的增加以及预测期内市场参与者的增长活动等因素，预计北美在预测期内也将以最高的复合年增长率增长。

新兴市场近期趋势

  • 2021 年 10 月，Spero Therapeutics Inc. 向 FDA 提交了一份新药申请 (NDA)，寻求批准替比培南 HBr 片剂用于治疗微生物特异性复杂性尿路感染 (cUTI)，包括肾盂肾炎。
  • 2021 年 9 月，印度领先的仿製药公司 BDR Pharma 将推出比阿培南，用于治疗腹腔内感染、下呼吸道感染和復杂尿路感染患者。我来了。

全球尿路感染药物市场报告范围

  • 历史数据：2019-2020-2021
  • 估算基准年：2021 年
  • 预测期：2022-2029
  • 报告范围：收入预测、公司排名、竞争格局、增长因素、趋势
  • 按地区划分：北美、欧洲、亚太地区、拉丁美洲、世界其他地区
  • 定制范围：免费报告定制（最多 8 个工作小时）。 按国家、地区和部门划分的范围的添加和更改。

本研究的目的是弄清近年来各个领域和国家的市场规模，并对未来几年的市场规模进行预测。 该报告旨在捕捉被调查国家工业的定性和定量方面的情况。

它还提供了关键方面的详细信息，例如决定市场未来增长的驱动因素和挑战。 此外，它还结合了利益相关者投资的潜在微观市场机会，以及主要参与者的竞争格局等详细分析。

内容

第 1 章执行摘要

  • 市场概况
  • 2019-2029 年各细分市场的全球市场估计和预测
    • 2019-2029 年按地区分列的尿路感染药物市场
    • 尿路感染药物市场，按药物分类，2019-2029 年
    • 尿路感染药物市场，按适应症，2019-2029
  • 主要趋势
  • 调查方法
  • 调查先决条件

第2章尿路感染药物全球市场的定义和范围

  • 调查目的
  • 市场定义和范围
    • 调查范围
    • 工业发展
  • 本次调查涵盖的年份
  • 货币兑换率

第三章尿路感染药物全球市场动态

  • 尿路感染用药市场影响分析（2019-2029）
    • 市场驱动因素
      • 肾结石和糖尿病的患病率增加
      • 联合药物的上市
    • 市场挑战
      • 在新兴国家/地区的认可度较低
    • 市场机会
      • 老年人口增加
      • 激活市场参与者的研发活动

第四章全球尿路感染药物市场行业分析

  • 波特 5 力模型
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间的敌对关係
  • 波特 5 力模型的未来方法 (2019-2029)
  • 害虫分析
    • 政治
    • 经济的
    • 社交
    • 技术
  • 最佳投资机会
  • 关键成功策略
  • 业内人士的前景
  • 分析师的建议和结论

第 5 章风险评估 COVID-19 影响

  • 评估 COVID-19 对行业的总体影响
  • COVID-19 之前和 COVID-19 之后的市场情景

第 6 章全球尿路感染药物市场：按药物分类

  • 市场概况
  • 尿路感染药物的全球市场：按药物、按性能 - 潜力分析
  • 2019-2029 年尿路感染药物全球市场估计和预测（按药物分类）
  • 尿路感染药物市场，按细分市场分析
    • 与青霉素联合使用
    • 奎诺酮类
    • 头孢类
    • 唑类和两性霉素 B
    • 硝基夫喃
    • 其他药物全球尿路感染治疗市场：按适应症分类的市场概况
  • 全球尿路感染药物市场：按适应症、按性能 - 潜力分析
  • 2019-2029 年全球尿路感染药物市场、按适应症估计和预测
  • 尿路感染药物市场、细分市场分析
    • 复杂性尿石症
    • 无并发症的尿石症
    • 其他适应症

第 7 章全球尿路感染药物市场：区域分析

  • 尿路感染药物市场，按地区划分的市场概况
  • 北美
    • 美国
      • 2019-2029 年各药物的估计和预测
      • 2019-2029 年各适应症的估计和预测
    • 加拿大
  • 欧洲尿路感染药物市场概况
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 其他欧洲
  • 亚太尿路感染药物市场概况
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 其他亚太地区
  • 拉丁美洲尿路感染药物市场概况
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地区
  • 世界其他地方

第 8 章衝突信息

  • 顶级市场策略
  • 公司简介
    • 阿斯利康
      • 关键信息
      • 概览
      • 财务（仅当数据可用时）
      • 产品概述
      • 近期趋势
    • Bayer AG
    • Cipla Inc.
    • GlaxoSmithKline PLC
    • Shionogi & Co. Ltd
    • Novartis AG
    • Pfizer
    • Merck & Co. Inc
    • Bristol-Myers Squibb Company
    • Almirall SA

第九章研究过程

  • 研究过程
    • 数据挖掘
    • 分析
    • 市场评估
    • 验证
    • 出版
  • 调查的特点
  • 调查先决条件

The global Urinary Tract Infection Therapeutics Market is valued at approximately USD 8.66 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 3 % over the forecast period 2022-2029. Urinary Tract Infection is one of the most common bacterial infections that occur majorly in women as compared to men. It affects the urinary tract. The Urinary Tract Infection Therapeutics market is expanding because of factors such as the rising growing prevalence of kidney stones and diabetes and the launch of combination drugs.

According to the World Health Organization 2019, diabetes claimed the lives of approximately 1.5 million people worldwide, Diabetes currently affects 537 million people worldwide, according to estimates. Projections show that by 2045, there will be 783 million diabetics worldwide. Whereas the rising geriatric population and growing R&D activities by market players create lucrative opportunities for the market. However, lack of awareness in developing countries hampers market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Urinary Tract Infection Therapeutics Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the increasing prevalence of kidney stones, and diabetes. , Also, North America is expected to grow with the highest CAGR during the forecast period, owing to factors such as increasing awareness towards UTIs, growing spending towards personal care, and growth activities by market players in the forecast period.

Major market players included in this report are:

  • AstraZeneca
  • Bayer AG
  • Cipla Inc.
  • GlaxoSmithKline PLC
  • Shionogi & Co. Ltd
  • Novartis AG
  • Pfizer
  • Merck & Co. Inc
  • Bristol-Myers Squibb Company
  • Almirall SA

Recent Developments in the Market:

  • In October 2021, Spero Therapeutics Inc. submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) seeking approval for tebipenem HBr tablets for the treatment of complicated urinary tract infections (cUTI) caused by susceptible microorganisms, including pyelonephritis.
  • In September 2021, Biapenem was introduced by BDR Pharma, one of India's leading generic pharmaceutical companies, to treat patients with intra-abdominal infections, lower respiratory infections, or complicated urinary tract infections.

Global Urinary Tract Infection Therapeutics Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Drug, Indication, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug:

  • Penicillin and Combinations
  • Quinolones
  • Cephalosporin
  • Azoles and Amphotericin B
  • Nitrofurans
  • Other Drugs

By Indication:

  • Complicated UTI
  • Uncomplicated UTI
  • Other Indications

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Urinary Tract Infection Therapeutics Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Urinary Tract Infection Therapeutics Market, by Drug, 2019-2029 (USD Billion)
    • 1.2.3. Urinary Tract Infection Therapeutics Market, by Indication, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Urinary Tract Infection Therapeutics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Urinary Tract Infection Therapeutics Market Dynamics

  • 3.1. Urinary Tract Infection Therapeutics Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing prevalence of kidney stones and diabetes
      • 3.1.1.2. Launch of combination drugs
    • 3.1.2. Market Challenges
      • 3.1.2.1. Lack of awareness in developing countries
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising geriatric population
      • 3.1.3.2. Growing R&D activities by market players

Chapter 4. Global Urinary Tract Infection Therapeutics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Urinary Tract Infection Therapeutics Market, by Drug

  • 6.1. Market Snapshot
  • 6.2. Global Urinary Tract Infection Therapeutics Market by Drug, Performance - Potential Analysis
  • 6.3. Global Urinary Tract Infection Therapeutics Market Estimates & Forecasts by Drug 2019-2029 (USD Billion)
  • 6.4. Urinary Tract Infection Therapeutics Market, Sub-Segment Analysis
    • 6.4.1. Penicillin and Combinations
    • 6.4.2. Quinolones
    • 6.4.3. Cephalosporin
    • 6.4.4. Azoles and Amphotericin B
    • 6.4.5. Nitrofurans
    • 6.4.6. Other Drugs Global Urinary Tract Infection Therapeutics Market, by Indication Market Snapshot
  • 6.5. Global Urinary Tract Infection Therapeutics Market by Indication, Performance - Potential Analysis
  • 6.6. Global Urinary Tract Infection Therapeutics Market Estimates & Forecasts by Indication 2019-2029 (USD Billion)
  • 6.7. Urinary Tract Infection Therapeutics Market, Sub Segment Analysis
    • 6.7.1. Complicated UTI
    • 6.7.2. Uncomplicated UTI
    • 6.7.3. Other Indications

Chapter 7. Global Urinary Tract Infection Therapeutics Market, Regional Analysis

  • 7.1. Urinary Tract Infection Therapeutics Market, Regional Market Snapshot
  • 7.2. North America Urinary Tract Infection Therapeutics Market
    • 7.2.1. U.S. Urinary Tract Infection Therapeutics Market
      • 7.2.1.1. Drug breakdown estimates & forecasts, 2019-2029
      • 7.2.1.2. Indication breakdown estimates & forecasts, 2019-2029
    • 7.2.2. Canada Urinary Tract Infection Therapeutics Market
  • 7.3. Europe Urinary Tract Infection Therapeutics Market Snapshot
    • 7.3.1. U.K. Urinary Tract Infection Therapeutics Market
    • 7.3.2. Germany Urinary Tract Infection Therapeutics Market
    • 7.3.3. France Urinary Tract Infection Therapeutics Market
    • 7.3.4. Spain Urinary Tract Infection Therapeutics Market
    • 7.3.5. Italy Urinary Tract Infection Therapeutics Market
    • 7.3.6. Rest of Europe Urinary Tract Infection Therapeutics Market
  • 7.4. Asia-Pacific Urinary Tract Infection Therapeutics Market Snapshot
    • 7.4.1. China Urinary Tract Infection Therapeutics Market
    • 7.4.2. India Urinary Tract Infection Therapeutics Market
    • 7.4.3. Japan Urinary Tract Infection Therapeutics Market
    • 7.4.4. Australia Urinary Tract Infection Therapeutics Market
    • 7.4.5. South Korea Urinary Tract Infection Therapeutics Market
    • 7.4.6. Rest of Asia Pacific Urinary Tract Infection Therapeutics Market
  • 7.5. Latin America Urinary Tract Infection Therapeutics Market Snapshot
    • 7.5.1. Brazil Urinary Tract Infection Therapeutics Market
    • 7.5.2. Mexico Urinary Tract Infection Therapeutics Market
    • 7.5.3. Rest of Latin America Urinary Tract Infection Therapeutics Market
  • 7.6. Rest of The World Urinary Tract Infection Therapeutics Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. AstraZeneca
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Product Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. Bayer AG
    • 8.2.3. Cipla Inc.
    • 8.2.4. GlaxoSmithKline PLC
    • 8.2.5. Shionogi & Co. Ltd
    • 8.2.6. Novartis AG
    • 8.2.7. Pfizer
    • 8.2.8. Merck & Co. Inc
    • 8.2.9. Bristol-Myers Squibb Company
    • 8.2.10. Almirall SA

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Urinary Tract Infection Therapeutics Market, report scope
  • TABLE 2. Global Urinary Tract Infection Therapeutics Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Urinary Tract Infection Therapeutics Market estimates & forecasts by Drug 2019-2029 (USD Billion)
  • TABLE 4. Global Urinary Tract Infection Therapeutics Market estimates & forecasts by Indication 2019-2029 (USD Billion)
  • TABLE 5. Global Urinary Tract Infection Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Urinary Tract Infection Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Urinary Tract Infection Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Urinary Tract Infection Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Urinary Tract Infection Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Urinary Tract Infection Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Urinary Tract Infection Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Urinary Tract Infection Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Urinary Tract Infection Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Urinary Tract Infection Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Urinary Tract Infection Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Urinary Tract Infection Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Urinary Tract Infection Therapeutics Market
  • TABLE 70. List of primary sources, used in the study of global Urinary Tract Infection Therapeutics Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Urinary Tract Infection Therapeutics Market, research methodology
  • FIG 2. Global Urinary Tract Infection Therapeutics Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Urinary Tract Infection Therapeutics Market, key trends 2021
  • FIG 5. Global Urinary Tract Infection Therapeutics Market, growth prospects 2022-2029
  • FIG 6. Global Urinary Tract Infection Therapeutics Market, porters 5 force model
  • FIG 7. Global Urinary Tract Infection Therapeutics Market, pest analysis
  • FIG 8. Global Urinary Tract Infection Therapeutics Market, value chain analysis
  • FIG 9. Global Urinary Tract Infection Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Urinary Tract Infection Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Urinary Tract Infection Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Urinary Tract Infection Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Urinary Tract Infection Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Urinary Tract Infection Therapeutics Market, regional snapshot 2019 & 2029
  • FIG 15. North America Urinary Tract Infection Therapeutics Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Urinary Tract Infection Therapeutics Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia Pacific Urinary Tract Infection Therapeutics Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Urinary Tract Infection Therapeutics Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Urinary Tract Infection Therapeutics Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable